Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma.zip

This file include datasets generated during analysis and R codes for graphical drawing. The main objective of submitted manuscript is as follows. The mechanism by which the tumor immune microenvironment is edited in human cancer tissues remains to be elucidated. Here, we analyzed the multi-omics of serial tumor and blood samples during lenvatinib monotherapy in 51 patients with advanced hepatocellular carcinoma.